Regression of coronary artery outward remodeling in patients with non-ST-segment acute coronary syndromes: A longitudinal study using noninvasive magnetic resonance imaging

American Heart Journal

Volumn 152, Issue 6, 2006, Pages 1123-1132

  Fernandes, Juliano Lara ^a   Serrano Jr , Carlos Vicente ^a   Blotta, Maria Heloisa S L ^b   Coelho, Otavio Rizzi ^b   Nicolau, Jose Carlos ^a   Ávila, Luis Francisco ^a   Rochitte, Carlos Eduardo ^a   Filho, Jose Rodrigues Parga ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRATE; TIROFIBAN;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTERY WALL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY; DISEASE COURSE; FEMALE; HUMAN; MALE; NON INVASIVE MEASUREMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RISK FACTOR; RISK MANAGEMENT; ST SEGMENT ELEVATION; THICKNESS; TREATMENT OUTCOME;

ACUTE DISEASE; ADRENERGIC BETA-ANTAGONISTS; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTICOAGULANTS; ASPIRIN; CORONARY DISEASE; CORONARY VESSELS; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; SYNDROME; TIME FACTORS;

EID: 33845204338     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2006.06.034     Document Type: Article

References (26)

1. Shah P.K. Mechanisms of plaque vulnerability and rupture. J Am Coll Cardiol 41 (2003) 15S-22S
2. Glagov S., Weisenberg E., Zarins C.K., et al. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med 316 (1987) 1371-1375
3. Schoenhagen P., Ziada K.M., Kapadia S.R., et al. Extent and direction of arterial remodeling in stable versus unstable coronary syndromes: an intravascular ultrasound study. Circulation 101 (2000) 598-603
4. Jensen L.O., Thayssen P., Pedersen K.E., et al. Regression of coronary atherosclerosis by simvastatin: a serial intravascular ultrasound study. Circulation 110 (2004) 265-270
5. Ward M.R., Pasterkamp G., Yeung A.C., et al. Arterial remodeling. Mechanisms and clinical implications. Circulation 102 (2000) 1186-1191
6. Fayad Z.A., Fuster V., Fallon J.T., et al. Noninvasive in vivo human coronary artery lumen and wall imaging using black-blood magnetic resonance imaging. Circulation 102 (2000) 506-510
7. Botnar R.M., Stuber M., Kissinger K.V., et al. Noninvasive coronary vessel wall and plaque imaging with magnetic resonance imaging. Circulation 102 (2000) 2582-2587
8. Desai M.Y., Lai S., Barmet C., et al. Reproducibility of 3D free-breathing magnetic resonance coronary vessel wall imaging. Eur Heart J 26 (2005) 2320-2324
9. Hazirolan T., Gupta S.N., Mohamed M.A., et al. Reproducibility of black-blood coronary vessel wall MR imaging. J Cardiovasc Magn Reson 7 (2005) 409-413
10. Kim W.Y., Stuber M., Bornert P., et al. Three-dimensional black-blood cardiac magnetic resonance coronary vessel wall imaging detects positive arterial remodeling in patients with nonsignificant coronary artery disease. Circulation 106 (2002) 296-299
11. Helft G., Worthley S.G., Fuster V., et al. Progression and regression of atherosclerotic lesions: monitoring with serial noninvasive magnetic resonance imaging. Circulation 105 (2002) 993-998
12. Worthley S.G., Helft G., Fuster V., et al. Serial in vivo MRI documents arterial remodeling in experimental atherosclerosis. Circulation 101 (2000) 586-589
13. Corti R., Fuster V., Fayad Z.A., et al. Lipid lowering by simvastatin induces regression of human atherosclerotic lesions: two years' follow-up by high-resolution noninvasive magnetic resonance imaging. Circulation 106 (2002) 2884-2887
14. Nissen S.E., Nicholls S.J., Sipahi I., et al. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. JAMA 295 (2006) 1556-1565
15. Nissen S.E., Tuzcu E.M., Schoenhagen P., et al. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. JAMA 291 (2004) 1071-1080
16. Schoenhagen P., Ziada K.M., Vince D.G., et al. Arterial remodeling and coronary artery disease: the concept of "dilated" versus "obstructive" coronary atherosclerosis. J Am Coll Cardiol 38 (2001) 297-306
17. Smits P.C., Pasterkamp G., Quarles van Ufford M.A., et al. Coronary artery disease: arterial remodelling and clinical presentation. Heart 82 (1999) 461-464
18. von Birgelen C., Klinkhart W., Mintz G.S., et al. Plaque distribution and vascular remodeling of ruptured and nonruptured coronary plaques in the same vessel: an intravascular ultrasound study in vivo. J Am Coll Cardiol 37 (2001) 1864-1870
19. Qiao J.H., and Fishbein M.C. The severity of coronary atherosclerosis at sites of plaque rupture with occlusive thrombosis. J Am Coll Cardiol 17 (1991) 1138-1142
20. Pasterkamp G., Galis Z.S., and de Kleijn D.P. Expansive arterial remodeling: location, location, location. Arterioscler Thromb Vasc Biol 24 (2004) 650-657
21. Hong M.K., Park S.W., Lee C.W., et al. Prospective comparison of coronary artery remodeling between acute coronary syndrome and stable angina in single-vessel disease: correlation between C-reactive protein and extent of arterial remodeling. Clin Cardiol 26 (2003) 169-172
22. Suzuki M., Inaba S., Nagai T., et al. Relation of C-reactive protein and interleukin-6 to culprit coronary artery plaque size in patients with acute myocardial infarction. Am J Cardiol 91 (2003) 331-333
23. Corti R., Fuster V., Fayad Z.A., et al. Effects of aggressive versus conventional lipid-lowering therapy by simvastatin on human atherosclerotic lesions: a prospective, randomized, double-blind trial with high-resolution magnetic resonance imaging. J Am Coll Cardiol 46 (2005) 106-112
24. von Birgelen C., Hartmann M., Mintz G.S., et al. Relation between progression and regression of atherosclerotic left main coronary artery disease and serum cholesterol levels as assessed with serial long-term (> or =12 months) follow-up intravascular ultrasound. Circulation 108 (2003) 2757-2762
25. Schwartz G.G., Olsson A.G., Ezekowitz M.D., et al. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA 285 (2001) 1711-1718
26. Cannon C.P., Braunwald E., McCabe C.H., et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 350 (2004) 1495-1504